The store will not work correctly when cookies are disabled.
3-(2,5-dimethoxyphenyl)-4-methyl-2-propyl-2,3-dihydropyrrolo[3,4-c]pyrrol-1(5H)-one
ID: ALA4066897
PubChem CID: 137633398
Max Phase: Preclinical
Molecular Formula: C18H22N2O3
Molecular Weight: 314.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCN1C(=O)c2c[nH]c(C)c2C1c1cc(OC)ccc1OC
Standard InChI: InChI=1S/C18H22N2O3/c1-5-8-20-17(16-11(2)19-10-14(16)18(20)21)13-9-12(22-3)6-7-15(13)23-4/h6-7,9-10,17,19H,5,8H2,1-4H3
Standard InChI Key: CHWGBKSAEUXZHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
10.5899 -15.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3850 -15.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9676 -14.9850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7557 -15.2340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4219 -14.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0923 -15.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8330 -16.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0088 -16.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5220 -16.6882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5033 -16.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1696 -16.0220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9144 -15.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3991 -14.5698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4219 -13.9230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1373 -13.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8485 -13.9230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5638 -13.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1373 -12.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4219 -12.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7108 -12.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9891 -12.2728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9891 -11.4487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7108 -13.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
4 8 1 0
8 9 2 0
7 10 2 0
10 11 1 0
6 12 2 0
11 12 1 0
12 13 1 0
5 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 2 0
14 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.39 | Molecular Weight (Monoisotopic): 314.1630 | AlogP: 3.30 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.56 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.86 | CX Basic pKa: ┄ | CX LogP: 2.65 | CX LogD: 2.65 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.92 | Np Likeness Score: -0.66 |
References
1. Ayoub AM, Hawk LML, Herzig RJ, Jiang J, Wisniewski AJ, Gee CT, Zhao P, Zhu JY, Berndt N, Offei-Addo NK, Scott TG, Qi J, Bradner JE, Ward TR, Schönbrunn E, Georg GI, Pomerantz WCK.. (2017) BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen., 60 (12): [PMID:28535045] [10.1021/acs.jmedchem.6b01336] |